Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UK
The drug known as AZD7442 has the potential to be given as a
preventative option for people exposed to the coronavirus, and to
treat and prevent disease progression in patients already infected by
the deadly virus.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biopharma-giant-astrazeneca-begins-coronavirus-dual-use-antibody-drug-trial-in-uk/articleshow/77741876.cms
preventative option for people exposed to the coronavirus, and to
treat and prevent disease progression in patients already infected by
the deadly virus.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biopharma-giant-astrazeneca-begins-coronavirus-dual-use-antibody-drug-trial-in-uk/articleshow/77741876.cms
Comments
Post a Comment